Levi & Korsinsky, LLP announces the commencement of a class action lawsuit in the USDC for the Eastern District of Pennsylvania on behalf of shareholders of Egalet Corporation (NASDAQ: EGLT) who purchased or otherwise acquired shares between December 15, 2015 and January 9, 2017.
The complaint alleges that, among other allegations, throughout the Class Period, Egalet made materially false and/or misleading statements concerning its lead product, ARYMO ER and the likelihood the product would receive oral abuse-deterrent labeling.
If you suffered a loss in Egalet you have until March 28, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
To receive more information, please fill out the form.